Patient Affordability Centers of Excellence
The next generation of brand support
White Paper
Dec 12, 2018

For many pharmaceutical brand teams, patient affordability programs represent the single largest line item in their profit and loss statements. To rationalize co-pay expenditures and ensure that they achieve their well-intentioned objectives, leading manufacturers are creating patient affordability Centers of Excellence ("CoEs") with the goal of applying cross-functional expertise to devising innovative patient affordability strategies.This paper reviews the state of co-pay programs today, explains why some patient affordability CoEs fail, presents success factors that companies should consider, and suggests what the future may bring.

You may also be interested in